Safety of infusing ipilimumab over 30 minutes Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Neoplasms

abstract

  • Ipilimumab at 3 mg/kg can be infused safely over 30 minutes with an acceptably low incidence of IRRs. After an IRR, patients can safely receive additional doses of ipilimumab with premedication.

publication date

  • October 20, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5087314

Digital Object Identifier (DOI)

  • 10.1200/JCO.2015.61.0030

PubMed ID

  • 26124475

Additional Document Info

start page

  • 3454

end page

  • 8

volume

  • 33

number

  • 30